Karen Ann Hardy, MD
Pediatric Pulmonology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hardy’s office at (650) 497-8000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G44088 · Current
Licensed to practise in California · since 1981 · expires 2026-12-31 · Medical College of Ohio.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatric Pulmonology
Medicaid work
$14,174 in 2024
Medicaid paid $14,174 for 87 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 87 | $14,174 |
| 2024 | 87 | 1 | 18 | $14,174 |
| 2023 | 194 | 3 | 22 | $20,824 |
| 2022 | 210 | 3 | 29 | $20,481 |
| 2021 | 315 | 4 | 24 | $33,008 |
| 2020 | 212 | 1 | 24 | $24,011 |
| 2019 | 248 | 3 | 20 | $23,837 |
| 2018 | 119 | 1 | 17 | $12,740 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 165 | $19,365 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 15 | $1,044 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 14 | $415 |
2022
| Long return visit (40+ min) | 165 | $17,354 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 32 | $2,756 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 13 | $370 |
2021
| Long return visit (40+ min) | 248 | $29,475 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 25 | $1,784 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 16 | $883 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 26 | $866 |
2020
| Long return visit (40+ min) | 212 | $24,011 |
2019
| Long return visit (40+ min) | 193 | $20,721 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 33 | $1,902 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 22 | $1,214 |
2018
| Long return visit (40+ min) | 119 | $12,740 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 18 Part D prescriptions in 2018. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2018 | 18 | None | 0% (0) | 67% | $26,107 |
| 2017 | 23 | None | 0% (0) | 74% | $46,865 |
| 2016 | 20 | None | 0% (0) | 90% | $60,434 |
| 2015 | 38 | None | 0% (0) | 79% | $34,774 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$19 in 2020
| 2020 | 1 | 1 | None | $19 |
| 2019 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Bexsero | $19 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2020-02-12 | Bexsero | $19 |
See earlier years (2019)
2019: $16
| Sanofi Pasteur | Fluzone High-Dose | $16 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| AbbVie Inc. · Creon · 2020 | Their institution | $295 |
| VIVUS, Inc. · Long-Term Study in US Cystic Fibrosis · 2020 | Their institution | $99 |
Professional record
- NPI
- 1508971938
- Licence
- CA G44088California G44088: Current · expires 2026-12-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G440880, NV 2085810
- Taxonomy
- Federal specialty code 2080P0214X (2080P0214X); Pediatrics (208000000X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2006-08-19
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.